185 related articles for article (PubMed ID: 33137455)
1. p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells.
Chang HW; Lee M; Lee YS; Kim SH; Lee JC; Park JJ; Nam HY; Kim MR; Han MW; Kim SW; Kim SY
Cell Signal; 2021 Jan; 77():109820. PubMed ID: 33137455
[TBL] [Abstract][Full Text] [Related]
2. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.
Suzuki S; Tanaka T; Poyurovsky MV; Nagano H; Mayama T; Ohkubo S; Lokshin M; Hosokawa H; Nakayama T; Suzuki Y; Sugano S; Sato E; Nagao T; Yokote K; Tatsuno I; Prives C
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7461-6. PubMed ID: 20351271
[TBL] [Abstract][Full Text] [Related]
3. Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.
Chang HW; Park JJ; Lee WH; Kim SH; Lee JC; Nam HY; Kim MR; Han MW; Lee YS; Kim SY; Kim SW
Cell Signal; 2024 Mar; 115():111029. PubMed ID: 38163576
[TBL] [Abstract][Full Text] [Related]
4. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
5. p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer.
Chang HW; Kim MR; Lee HJ; Lee HM; Kim GC; Lee YS; Nam HY; Lee M; Jang HJ; Lee KE; Lee JC; Byun Y; Kim SW; Kim SY
Oncogene; 2019 May; 38(19):3729-3742. PubMed ID: 30664690
[TBL] [Abstract][Full Text] [Related]
6. Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling Hypoxia.
Matschke J; Riffkin H; Klein D; Handrick R; Lüdemann L; Metzen E; Shlomi T; Stuschke M; Jendrossek V
Antioxid Redox Signal; 2016 Jul; 25(2):89-107. PubMed ID: 27021152
[TBL] [Abstract][Full Text] [Related]
7. Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation.
Xiang L; Xie G; Liu C; Zhou J; Chen J; Yu S; Li J; Pang X; Shi H; Liang H
Biochim Biophys Acta; 2013 Dec; 1833(12):2996-3005. PubMed ID: 23954443
[TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
Vibhuti A; Muralidhar K; Dwarakanath BS
J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
[TBL] [Abstract][Full Text] [Related]
9. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N
Oncotarget; 2017 Jul; 8(30):49275-49292. PubMed ID: 28525376
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers.
Rashmi R; Jayachandran K; Zhang J; Menon V; Muhammad N; Zahner M; Ruiz F; Zhang S; Cho K; Wang Y; Huang X; Huang Y; McCormick ML; Rogers BE; Spitz DR; Patti GJ; Schwarz JK
Mol Cancer Ther; 2020 Dec; 19(12):2465-2475. PubMed ID: 33087507
[TBL] [Abstract][Full Text] [Related]
11. Glutaminases regulate glutathione and oxidative stress in cancer.
Matés JM; Campos-Sandoval JA; de Los Santos-Jiménez J; Márquez J
Arch Toxicol; 2020 Aug; 94(8):2603-2623. PubMed ID: 32681190
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.
Wilkie MD; Anaam EA; Lau AS; Rubbi CP; Jones TM; Boyd MT; Vlatković N
Cancer Lett; 2020 May; 478():107-121. PubMed ID: 32113989
[TBL] [Abstract][Full Text] [Related]
13. Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.
Rashmi R; Huang X; Floberg JM; Elhammali AE; McCormick ML; Patti GJ; Spitz DR; Schwarz JK
Cancer Res; 2018 Mar; 78(6):1392-1403. PubMed ID: 29339540
[TBL] [Abstract][Full Text] [Related]
14. p53 Protects lung cancer cells against metabolic stress.
Sinthupibulyakit C; Ittarat W; St Clair WH; St Clair DK
Int J Oncol; 2010 Dec; 37(6):1575-81. PubMed ID: 21042727
[TBL] [Abstract][Full Text] [Related]
15. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
16. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
Lu H; Li X; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
[TBL] [Abstract][Full Text] [Related]
17. Redox control of glutamine utilization in cancer.
Alberghina L; Gaglio D
Cell Death Dis; 2014 Dec; 5(12):e1561. PubMed ID: 25476909
[TBL] [Abstract][Full Text] [Related]
18. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression.
Eichelmann AK; Mayne GC; Chiam K; Due SL; Bastian I; Butz F; Wang T; Sykes PJ; Clemons NJ; Liu DS; Michael MZ; Karapetis CS; Hummel R; Watson DI; Hussey DJ
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074015
[No Abstract] [Full Text] [Related]
20. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.
Hu W; Zhang C; Wu R; Sun Y; Levine A; Feng Z
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7455-60. PubMed ID: 20378837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
